Clinical Trials Browser

Interventional × titanium silicide × Thoracic × Clear all

NCT00874328 2010-10-25

A Study of TS-1 Plus Irinotecan and Cisplatin (IP) for Patients With Stage IIIB/IV Non Small Cell Lung Cancer (NSCLC)

Phase 1/2 Unknown

Carcinoma, Non-Small-Cell Lung